Pfizer expects the end of the pandemic in 2022, but it will be necessary to be vaccinated annually

The CEO of pharmaceutical company Pfizer, developer of one of the most effective vaccines against the coronavirus, predicted this Sunday the “normal life” after the Covid-19 pandemic he will be back in a year, although he said it is likely that he will need to be vaccinated “annually” against the disease.

“In a year, I think we can get back to normal life, ”he said. Albert Bourla in an interview on the television network ABC. “We hope to be able to vaccinate all these vulnerable people so that we can end this pandemic. “

The executive, however, explained that the end of the pandemic will not mean the end of the virus, and stressed that it is likely that new variants will emerge which, however, can be controlled with vaccines. The drugmaker, in fact, is pushing for drug regulators to grant approval for a booster dose.

Vaccinated pregnant women pass protection to their babies, study finds

Bourla said that “the most likely scenario for me is that because the virus has spread across the world, we will continue to see new variants emerge. “

Bourla’s statements came two days after the U.S. Centers for Disease Control and Prevention (CDC) approved the application of a third dose of the Pfizer-BioNTech vaccine for those over 65 and those in the need at risk.

Pandemic could end in a year, predicts Moderna director

The vaccine from the American company Pfizer and the German BioNTech is the only one to have Full approval for use by US regulators., like the other two available, the double dose of Moderna and the single dose of Johnson & Johnson, have emergency clearance.

Laboratory plans to bill $ 33,500 million this year for worldwide sales of 2,100 million doses of coronavirus vaccine. And sales could grow further as the company advocates a third dose of its vaccine to make it more effective, at a time when the Delta variant of the coronavirus is causing serious epidemics in Asia, Africa, Europe and the United States.

ds